About Leadtek Medical

Innovation & Quality
Moving Leadtek Forward

Leadtek Symbolic

Leadtek

Leadtek Research Inc.
Established in 1986, Leadtek is a globally renowned developer and manufacturer of computer and smart medical technologies, and a long-term partner of NVIDIA.
We remain committed to the core belief of "Research Innovation and Quality First."
LEADTEK = Leading Technology

Company Profile

Basic Information
  • Stock Code: 2465
  • Authorized Capital: NTD 4 billion
    (NTD 600 million reserved for convertible corporate bonds and employee stock options)
  • Chairman / General Manager: Mr. K.S. Lu
  • Leadtek Official Website: www.leadtekbiomed.com
  • Listing Date: September 19, 2001
  • Spokesperson / Special Assistant to the Chairman: Mr. Chih-Kun Yang
  • Paid-in Capital: NTD 839,460,310
  • Number of Issued Common Shares: 83,946,031 shares

Competitive Advantages

Leadtek's product lineup includes GeForce graphics cards, NVIDIA RTX GPUs, AI workstations and servers, AI management software, desktop virtualization solutions (Zero Client/Thin Client), smart medical/healthcare solutions, and big data solutions. According to the *2022 CommonWealth Magazine's* Top 2000 Enterprises Survey, Leadtek was ranked 379th in the "Manufacturing Industry Overall Ranking" for 2021, demonstrating remarkable performance.

Leadtek began its investment in smart healthcare and health management in 2000 with WeGene Genetic Technology. WeGene focuses on heart rate variability (HRV), electrocardiogram (ECG), and wireless application products. In terms of autonomic nervous system analysis and testing, WeGene holds the largest market share in Taiwan, with its medical devices adopted by renowned large hospitals across Taiwan and China. In 2010, Leadtek established its healthcare brand *amor*. The word *amor* originates from Spanish, meaning "love." Through the *amor* brand, Leadtek aims to convey a spirit of caring for health and providing premium medical health products, becoming a trusted health steward for every consumer. In 2014, the *amor H1 Heart Rate Fitness Recorder* was launched. In 2018, Leadtek introduced the *amor H2 Health Band*. Building on its success, the *amor H2 Plus Wearable ECG Recorder* was released in 2020, integrating personalized AI health management with features such as ECG measurement, event recording, continuous heart rate monitoring, and sleep/health index tracking. This product meets the needs of precision hospital diagnostics and home telehealth services. Research from Taiwan's medical centers shows that patients wearing the *H2 Plus* post-hospitalization can reduce readmission rates by up to 75% through real-time monitoring and medication adjustments.

In 2021, the *amor HRV Guard* was launched, offering an efficient and convenient cardiac testing tool. In just 30 seconds, it can measure users' average heart rate, heart rate variability, ECG, and arrhythmias. This device is widely applicable in clinics and healthcare institutions, supporting 3/5-minute spectral analysis and tracking user conditions for clinical diagnosis reference.

In 2019, Leadtek acquired the globally renowned pulse oximeter brand *Alvital*. Its non-invasive, rapid, and accurate blood oxygen saturation (SpO2) and heart rate monitoring technology received government procurement approval during the pandemic. The product has earned certifications from the US FDA, Japan PMDA, and Taiwan TFDA, playing a crucial role in fighting COVID-19 in severely affected regions. In 2023, Leadtek introduced a home sleep monitoring service to address the needs of insomnia patients with market-oriented solutions.

In smart healthcare applications, Leadtek integrates artificial intelligence and IoT technology (AIoT+Medical+Health) to prioritize physical and mental health, lifestyle tracking, and health management. By leveraging wearable devices such as the *amor H2 Health Band*, *amor H2 Plus Wearable ECG Recorder*, and *amor HRV Guard Autonomic Nervous System Tester*, combined with the *amor Physical and Mental Health Management Platform*, Leadtek provides professional data analysis and AI applications. The platform aggregates data on activity levels, sleep records, fatigue index, circulatory index, stress index, heart rate, ECG, cardiac contractility, blood pressure, blood oxygen levels, atrial fibrillation, and arterial stiffness. In collaboration with medical centers, Leadtek has achieved remarkable results in cardiac disease tracking using its advanced ECG and phonocardiogram technology.

Leadtek integrates key health risk factors (blood oxygen levels, ECG, lifestyle stress, cardiac vitality, and blood pressure/blood sugar/weight) into its platform, offering comprehensive AI risk prediction. In 2022, the *amor Digital Stethoscope* received critical acclaim, followed by the 2023 launch of the *amor Optical Molecular Detection Device*, *amor H3 Plus Patch* (6-lead ECG detection), and *8D52 Long-Term Sleep Oxygen Monitoring*. These innovations contribute to a comprehensive smart ward solution.

In recent years, Leadtek has achieved significant success in the fields of smart medical ecosystems and cardiovascular health management. Leadtek collaborates with over 200 medical institutions in Taiwan and has established a presence in more than 2,000 pharmacies, medical equipment stores, and health product retail channels. Committed to innovative research and development, Leadtek provides diverse medical solutions, including device monitoring, platform supervision, and health supplements, along with flexible rental business plans. These offerings facilitate seamless adoption across industries, addressing a wide range of healthcare needs.

Milestones

  • 2024
  • BtNPN Plant Nano Patches successfully deployed across over 1,000 physical retail locations in Taiwan.
  • 2023
  • Launched AI Smart Ward Solutions.
  • Introduced the 8D52 Wearable Pulse Oximeter with integrated blood oxygen and heart rate monitoring.
  • 2022
  • Launched the new 8D02 Pulse Oximeter.
  • 2020
  • Taiwan's first ECG recorder integrated with National Health Insurance Card for more convenient autonomic nervous system applications.
  • Taiwan's first medical wearable device integrating ECG and PPG optical technology.
  • Selected as the top government procurement choice for COVID-19 emergency supplies, leading the pulse oximeter market in Taiwan.
  • The *amor* Physical and Mental Health Management Platform won the Taiwan Excellence Award.
  • 2019
  • Deployed health monitoring stations across New Taipei City senior citizen clubs, long-term care centers, and remote rural areas to track residents' health.
  • 2016
  • Taiwan's only patch-type Heart Rate Variability (HRV) Analyzer.
  • 2015
  • Introduced unique cardiac and phonocardiogram coaxial analysis technology, adopted by Taiwan's top 10 medical centers and major hospitals, advancing precision medicine.
  • Integrated stress assessment into major medical and psychological counseling systems, becoming Taiwan's leading brand in autonomic nervous system analysis.
  • 2014
  • *amor H1* Wearable Device won the Japan *Good Design* Award.
  • 2006
  • Autonomic Nervous System Analyzer obtained TFDA/CFDA certification.
TOP